Angiotech Pharmaceuticals recently announced positive interim 12-month safety
results from its novel and proprietary Vascular Wrap paclitaxel-eluting mesh
trial presented at the VEITHsymposium in New York. This European first-in-man
pilot study is designed to evaluate the safety of a novel and proprietary drug-loaded
Vascular Wrap in the prevention of stenosis after peripheral bypass surgery.